increased sarcoma incidence_Tg(Acta2-RAC1*G12V)33Pjgc/Tg(Acta2-RAC1*G12V)33Pjgc

http://metadb.riken.jp/0002032IC57BL6FVBNTgActa2RAC1G12V33PjgcTgActa2RAC1G12V33PjgcTgActa2RAC1G12V33Pjgc

increased sarcoma incidence_Tg(Acta2-RAC1*G12V)33Pjgc/Tg(Acta2-RAC1*G12V)33Pjgc

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 33, Pascal J Goldschmidt-Clermont
  http://metadb.riken.jp/db/mgi_rdf/MGI:3850846

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Acta2-RAC1*G12V)33Pjgc/Tg(Acta2-RAC1*G12V)33Pjgc

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Acta2-RAC1*G12V)33Pjgc

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sarcoma incidence
  http://purl.obolibrary.org/obo/MP_0002032

文献

http://purl.org/net/cito/citesAsAuthority

• Qi. Ma, et.al., Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma., Proceedings of the National Academy of Sciences of the United States of America, 2009, 106
  http://rdf.ncbi.nlm.nih.gov/pubmed/19429708